TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24970718

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 26088854

Group type: EXPERIMENTAL
Intervention: Restrictive volume of intraoperative fluid (≤8 mL/kg/h)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Liberal volume of intraoperative fluid (>8 mL/kg/h)
Number of subjects: 16
Study: 23819476

Group type: EXPERIMENTAL
Intervention: Usual care plus additional early initiation of secondary prevention drugs (blood-pressure lowering protocol, simvastatin 40 mg, dipyridamole 200 mg m/r bd)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (initiation of aspirin and referral to a TIA clinic)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pilot trial
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Diagnostic accuracy sub-study
Number of subjects: 100
Study: 20886725

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 0
Study: 18637030

Group type: EXPERIMENTAL
Intervention: Induction regimen including fludarabine, arabinosyl cytosine and idarubicin, with or without etoposide (FLAI/FLAIE)
Number of subjects: 224
Study: 16173864

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) with homework assignments
Number of subjects: 60
Study: 12695287

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg BID)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 9893077

Group type: EXPERIMENTAL
Intervention: Maternal smoking during pregnancy
Number of subjects: 330
Study: 7751429

Group type: EXPERIMENTAL
Intervention: Indenolol (120 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2208416

Group type: EXPERIMENTAL
Intervention: Xintongkang capsule
Number of subjects: 267

Group type: COMPARATOR
Intervention: Persantin and aspirin (Control)
Number of subjects: 267
Study: 6255844

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ketoconazole (after placebo)
Number of subjects: 12
Study: 31355456

Group type: EXPERIMENTAL
Intervention: Atacicept alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atacicept complexed with APRIL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multimeric form of atacicept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study: 27710700

Group type: EXPERIMENTAL
Intervention: Back extensor strengthening exercises
Number of subjects: 183

Group type: COMPARATOR
Intervention: Pharmacotherapy and weight-bearing and balance-training exercises (Control)
Number of subjects: 183
Study: 25943440

Group type: EXPERIMENTAL
Intervention: Upper extremity aerobic exercise (UEAE)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 52
Study: 23766391

Group type: EXPERIMENTAL
Intervention: Multimodal mind-body program (MMMT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Walking intervention
Number of subjects: 64
Study: 21256048

Group type: EXPERIMENTAL
Intervention: Tadalafil 40 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Tadalafil 40 mg add-on to bosentan
Number of subjects: 405

Group type: COMPARATOR
Intervention: PBO
Number of subjects: 405

Group type: COMPARATOR
Intervention: PBO add-on to bosentan
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Tadalafil monotherapy and as add-on
Number of subjects: 405
Study: 19120729

Group type: EXPERIMENTAL
Intervention: Suction of oral secretion before each positional care
Number of subjects: 261

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 261
Study: 17534812

Group type: EXPERIMENTAL
Intervention: 1% unpreserved lidocaine (Group 2)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Balanced salt solution (Group 1)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intravenous sedation
Number of subjects: 96
Study: 15155352

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (66% nitrous oxide used in group N)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Air (no nitrous oxide used in group A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Postoperative airway complications
Number of subjects: 24
Study: 11822847

Group type: EXPERIMENTAL
Intervention: Implementation of clinical practice guidelines for the management of venous leg ulcers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preliminary needs analysis of contextual hurdles and levers
Number of subjects: 0
Study: 9503547

Group type: EXPERIMENTAL
Intervention: FK 506
Number of subjects: 41

Group type: COMPARATOR
Intervention: CyA
Number of subjects: 41
Study: 9175947

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hydrocortisone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 2126475

Group type: EXPERIMENTAL
Intervention: Natural porcine surfactant treatment
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no surfactant treatment)
Number of subjects: 33
Study: 6454596

Group type: EXPERIMENTAL
Intervention: Ro 11-1430
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tretinoin
Number of subjects: 60
Study: 31914930

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control (Normal saline)
Number of subjects: 122
Study: 31671514

Group type: EXPERIMENTAL
Intervention: Combined exercise program (Korean dance and yoga), 60 min/day, 3 times/week for 12 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 25
Study: 27980249

Group type: EXPERIMENTAL
Intervention: Active rest (short-time exercise) program consisting of warm-up, cognitive functional training, aerobic exercise, resistance training, and cool-down for 10 minutes per day, 3 times per week for 10 weeks
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Active rest (short-time exercise) program
Number of subjects: 59
Study: 25242059

Group type: EXPERIMENTAL
Intervention: Modified Stoplight Diet (SLDm) supplemented with portion-controlled meals
Number of subjects: 126

Group type: COMPARATOR
Intervention: Usual Care (UC) - modified version of the MyPlate diet
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Modified Stoplight Diet (SLDm)
Number of subjects: 126
Study: 23886232

Group type: EXPERIMENTAL
Intervention: Auvi-Q
Number of subjects: 71

Group type: COMPARATOR
Intervention: EpiPen
Number of subjects: 71
Study: 20167430

Group type: EXPERIMENTAL
Intervention: Intradiscal methylene blue injection
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 72
Study: 18254487

Group type: EXPERIMENTAL
Intervention: Parecoxib, 40 mg
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 16494640

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of ramipril 2.5 mg/felodipine ER 2.5 mg
Number of subjects: 149

Group type: COMPARATOR
Intervention: Ramipril 2.5 mg
Number of subjects: 149

Group type: COMPARATOR
Intervention: Felodipine ER 2.5 mg
Number of subjects: 149
Study: 14627848

Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET
Number of subjects: 16

Group type: COMPARATOR
Intervention: [99mTc]pertechnetate scintigraphy
Number of subjects: 16
Study: 10764312

Group type: EXPERIMENTAL
Intervention: Systemic corticosteroid treatment arm
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: FEV(1) at entry into the study
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Change in FEV(1) over the first two Study Days
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Treatment failure (defined as death, intubation, readmission for COPD, or intensification of drug therapy)
Number of subjects: 261
Study: 8916534

Group type: EXPERIMENTAL
Intervention: Higher dust levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher concentrations of nitrogen dioxide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher TVOCs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher nitrogen dioxide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher total contaminant load
Number of subjects: 0
Study: 1756437

Group type: EXPERIMENTAL
Intervention: Indomethacin, 150 mg daily for 3 days
Number of subjects: 9
Study: 7059922

Group type: EXPERIMENTAL
Intervention: Counseling by a counselor
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 120
Study: 30581128

Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the right DLPFC
Number of subjects: 54

Group type: COMPARATOR
Intervention: Anodal tDCS to the left DLPFC
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 54
Study: 27385542

Group type: EXPERIMENTAL
Intervention: Dynamic stretching
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: FIFA 11+
Number of subjects: 22
Study: 27283479

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (n=2543)
Number of subjects: 7447

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts (n=2454)
Number of subjects: 7447

Group type: COMPARATOR
Intervention: Control diet (advice to reduce dietary fat; n=2450)
Number of subjects: 7447
Study: 24410411

Group type: EXPERIMENTAL
Intervention: Active exercise
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage (MLD)
Number of subjects: 89
Study: 22995880

Group type: EXPERIMENTAL
Intervention: Intraprocedural complications (n=166, 11.4%)
Number of subjects: 1452

Group type: COMPARATOR
Intervention: No intraprocedural complications
Number of subjects: 1452
Study: 19545851

Group type: EXPERIMENTAL
Intervention: Soft contact lenses
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rigid gas-permeable (GP) contact lenses
Number of subjects: 20
Study: 17634903

Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron intravenously for 5 days
Number of subjects: 108

Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 108

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 108
Study: 15347114

Group type: EXPERIMENTAL
Intervention: Fundus-first laparoscopic cholecystectomy
Number of subjects: 145

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy
Number of subjects: 145
Study: 11590553

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT) with estradiol 2 mg/day for 10 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group of 12 healthy postmenopausal women (no ERT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group of 11 comparably healthy age-matched men
Number of subjects: 30
Study: 9586605

Group type: EXPERIMENTAL
Intervention: External fixed-rate signal generator (cardiac simulator)
Number of subjects: 933

Group type: COMPARATOR
Intervention: Electrocardiogram-gated SWL (no simulator)
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 933
Study: 8006520

Group type: EXPERIMENTAL
Intervention: Palmitoleic acid
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Palmitic acid
Number of subjects: 34

Group type: COMPARATOR
Intervention: Oleic acid
Number of subjects: 34
Study: 2461406

Group type: EXPERIMENTAL
Intervention: terfenadine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: loratadine
Number of subjects: 14

Group type: COMPARATOR
Intervention: control day
Number of subjects: 14
Study: 31899552

Group type: EXPERIMENTAL
Intervention: BMT‐CARE intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 31573918

Group type: COMPARATOR
Intervention: Comments on Google
Number of subjects: 849

Group type: COMPARATOR
Intervention: Comments on Medicosearch
Number of subjects: 849

Group type: COMPARATOR
Intervention: Comments on DocApp
Number of subjects: 849

Group type: COMPARATOR
Intervention: Comments on OkDoc
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Overall comments
Number of subjects: 849

Group type: COMPARATOR
Intervention: Negative comments on Google
Number of subjects: 849

Group type: COMPARATOR
Intervention: Negative comments regarding physicians in Zurich
Number of subjects: 849

Group type: COMPARATOR
Intervention: Negative comments from specialists
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Interpersonal issues
Number of subjects: 849
Study: 28329243

Group type: EXPERIMENTAL
Intervention: Adherent participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-adherent participants
Number of subjects: 0
Study: 25111547

Group type: EXPERIMENTAL
Intervention: Self-enhancing writing (downward social comparison) among European Americans
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Self-improving writing (persistence) among European Americans
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Self-improving writing (persistence) among Asian Americans
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Self-enhancing writing (downward social comparison) among Asian Americans
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Self-improving writing (situational attributions) among Asian Americans
Number of subjects: 34
Study: 23000088

Group type: EXPERIMENTAL
Intervention: Ra 223 at 25 kBq/kg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Ra 223 at 50 kBq/kg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Ra 223 at 80 kBq/kg
Number of subjects: 122
Study: 20821047

Group type: EXPERIMENTAL
Intervention: Letrozole for 12 weeks followed by Anastrozole for 12 weeks
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Anastrozole for 12 weeks followed by Letrozole for 12 weeks
Number of subjects: 181

Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 181

Group type: COMPARATOR
Intervention: Anastrozole
Number of subjects: 181

Group type: COMPARATOR
Intervention: Both agents
Number of subjects: 181
Study: 18204797

Group type: EXPERIMENTAL
Intervention: Knack maneuver
Number of subjects: 93
Study: 17199783

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Valproate + Carbamazepine (combined therapy)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Long-term treatment (>10 years) with Valproate, Carbamazepine, and combined therapy
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Serum concentration of Valproate
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Serum concentration of Carbamazepine
Number of subjects: 114
Study: 12644958

Group type: EXPERIMENTAL
Intervention: Flumazenil (1 mg/h, continuous IV infusion for 5 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (saline solution, equal volume for 5 hours)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Flumazenil and Placebo
Number of subjects: 40
Study: 11054226

Group type: EXPERIMENTAL
Intervention: Extended saphenofemoral junction (SFJ) ligation
Number of subjects: 180

Group type: COMPARATOR
Intervention: No high ligation
Number of subjects: 180
Study: 9052355

Group type: EXPERIMENTAL
Intervention: Acute alcohol ingestion (ethanol blood concentration 1.3 +/- 0.4%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Juice control
Number of subjects: 20
Study: 8422814

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg b.i.d.)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Gemfibrozil and Placebo
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 442
Study: 3510043

Group type: EXPERIMENTAL
Intervention: Barium suspension with optimal viscosity (suspended with 65-70 ml water)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Barium suspension with high viscosity (same batch number, suspended with different water amounts)
Number of subjects: 600
Study: 30040707

Group type: EXPERIMENTAL
Intervention: IASTM technique
Number of subjects: 45
Study: 27163500

Group type: EXPERIMENTAL
Intervention: Belimumab 200 mg subcutaneously via autoinjector
Number of subjects: 81

Group type: COMPARATOR
Intervention: Belimumab 200 mg subcutaneously via prefilled syringe
Number of subjects: 81
Study: 24829212

Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 2413

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2413
Study: 23028241

Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine, 10 mL (Group I)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 9 mL of 0.5% lidocaine mixed with 1 mL of 6 mg of nonparticulate betamethasone (Group II)
Number of subjects: 140
Study: 19910499

Group type: EXPERIMENTAL
Intervention: Registered dietitian-led intervention group (n = 75)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (routine care, n = 79)
Number of subjects: 154
Study: 17651142

Group type: EXPERIMENTAL
Intervention: Aeroallergen sensitization assessment in 40-year-olds
Number of subjects: 7820
Study: 16128861

Group type: EXPERIMENTAL
Intervention: 200 mg acarbose
Number of subjects: 28

Group type: COMPARATOR
Intervention: 100 g saccharose
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 28
Study: 12453138

Group type: EXPERIMENTAL
Intervention: Bioengineered skin construct
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Debridement Performance Index
Number of subjects: 143
Study: 10450062

Group type: EXPERIMENTAL
Intervention: SangCya (test)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Neoral (reference)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SangCya and Neoral
Number of subjects: 20
Study: 8643419

Group type: EXPERIMENTAL
Intervention: Previous Colles fracture group (n = 63)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (n = 53)
Number of subjects: 63
Study: 2145770

Group type: EXPERIMENTAL
Intervention: 150 micrograms of desogestrel and 30 micrograms of ethinyl estradiol
Number of subjects: 60

Group type: COMPARATOR
Intervention: 75 micrograms of gestodene and 30 micrograms of ethinyl estradiol
Number of subjects: 60
Study: 1101231

Group type: EXPERIMENTAL
Intervention: Systematic psychologic preparation and continued supportive care
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no systematic psychologic preparation and supportive care)
Number of subjects: 80
Study: 31820593

Group type: EXPERIMENTAL
Intervention: Oxycodone 0.1 mg/kg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.1 μg/kg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 94
Study: 31437853

Group type: EXPERIMENTAL
Intervention: 35% CO2 challenge
Number of subjects: 80

Group type: COMPARATOR
Intervention: Room air inhalation
Number of subjects: 80
Study: 27526332

Group type: EXPERIMENTAL
Intervention: Cold pressor test
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bicycling exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cold pressor test and bicycling EIH
Number of subjects: 14
Study: 26118144

Group type: EXPERIMENTAL
Intervention: Community health worker-led group sessions based on the American Heart Association's Simple Seven curriculum (six sessions, one per month)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 0
Study: 22951625

Group type: EXPERIMENTAL
Intervention: Aerobic training (6 months vigorous aerobic exercise, AT group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-aerobic group (6 months of no aerobic exercise, NA group)
Number of subjects: 52
Study: 22043310

Group type: EXPERIMENTAL
Intervention: Patient administered measures (Shared Decision Making Questionnaire, Control Preference Scale & Decisional Conflict Scale)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Observer ratings (OPTION)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Patient administered measures
Number of subjects: 79

Group type: COMPARATOR
Intervention: Observer and patient judges
Number of subjects: 79
Study: 18364522

Group type: EXPERIMENTAL
Intervention: Walking routes
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Walking-while-working
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 17166388

Group type: EXPERIMENTAL
Intervention: Home-produced Nedaplatin plus 5-fluorouracil (5-FU)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cisplatin (DDP) plus 5-fluorouracil (5-FU)
Number of subjects: 52
Study: 12716672

Group type: EXPERIMENTAL
Intervention: Methionine intake of 14 mg . kg(‐)(1) . d(‐)(1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Methionine intake of 15 mg . kg(‐)(1) . d(‐)(1)
Number of subjects: 21
Study: 10737537

Group type: EXPERIMENTAL
Intervention: Autologous tumor cell vaccine (AV) plus bCG with sequential administration of IFN gamma and IFN alpha
Number of subjects: 14
Study: 8737615

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Oral estradiol
Number of subjects: 25
Study: 1332634

Group type: EXPERIMENTAL
Intervention: Estrogen-norethindrone
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Estrogen-norethindrone + Cholecalciferol
Number of subjects: 74

Group type: COMPARATOR
Intervention: Cholecalciferol
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 3968608

Group type: EXPERIMENTAL
Intervention: Increased fluid intake (mean 59%, range 26% to 140%)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Baseline fluid intake
Number of subjects: 26
Study: 31379195

Group type: EXPERIMENTAL
Intervention: Olanzapine disintegrating tablets at a dose of 5 mg
Number of subjects: 0
Study: 28844333

Group type: EXPERIMENTAL
Intervention: Knee targeted exercises combined with foot targeted exercises and foot orthoses
Number of subjects: 40

Group type: COMPARATOR
Intervention: Knee targeted exercises
Number of subjects: 40
Study: 26815638

Group type: EXPERIMENTAL
Intervention: 6-month participatory, team-based educational intervention consisting of 12 biweekly learning sessions
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 6-month participatory, team-based educational intervention
Number of subjects: 29
Study: 24604216

Group type: EXPERIMENTAL
Intervention: Two-point Dixon-based MRI (2pt-MRIDIXON)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Visual assessment of muscle fat content (MFC)
Number of subjects: 50
Study: 21835468

Group type: EXPERIMENTAL
Intervention: Active TCES
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (sham TCES)
Number of subjects: 36